Eton Pharmaceuticals Inc (ETON)
3.76
+0.05
(+1.35%)
USD |
NASDAQ |
May 06, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Cash from Investing (TTM): -0.775M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.775M |
September 30, 2023 | -0.012M |
June 30, 2023 | -2.012M |
March 31, 2023 | -2.773M |
December 31, 2022 | -2.788M |
September 30, 2022 | -6.03M |
June 30, 2022 | -4.032M |
March 31, 2022 | -2.574M |
December 31, 2021 | -2.559M |
September 30, 2021 | 0.651M |
June 30, 2021 | 0.651M |
Date | Value |
---|---|
March 31, 2021 | -0.046M |
December 31, 2020 | -0.05M |
September 30, 2020 | -0.79M |
June 30, 2020 | -0.82M |
March 31, 2020 | -1.462M |
December 31, 2019 | -1.846M |
September 30, 2019 | -1.116M |
June 30, 2019 | -1.134M |
March 31, 2019 | -0.533M |
December 31, 2018 | -0.236M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.03M
Minimum
Sep 2022
0.651M
Maximum
Jun 2021
-1.554M
Average
-1.134M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Eli Lilly and Co | -7.642B |
Evoke Pharma Inc | -- |
Outlook Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |